Alzheimer's disease affects over 6.7 million Americans and is projected to affect 13 million by 2050. Alzheimer's is a disease that impacts memory, thinking, and behavior- with no known cure.
Neuropsychiatric symptoms, including psychosis, agitation, depression, and anxiety, are common in individuals with Alzheimer's. Traditional medications to manage these symptoms may have adverse side effects, highlighting the need for alternative therapeutic strategies.
Neuroprotection: a Therapeutic Approach
Neuroprotection is a therapeutic approach that prevents Neuronal Cell Death by inhibiting the pathogenic cascade that results in cell dysfunction and death. Oxidative stress and Excitotoxicity are the two primary targets of neuroprotective interventions. CBD has antioxidant benefits that have shown potential for neuroprotection by modulating toxic levels of glutamate, a neurotransmitter that can damage nerve cells and the brain in high amounts.
In addition to its antioxidant benefits, CBD interacting with CB2 receptors found in microglia cells has shown promise for neuroprotective benefits. Microglia cells are immune cells in the central nervous system that play important roles in brain infections and inflammation. CBD may target specific behavioral symptoms common in Alzheimer's, including sleep disorders, anxiety, agitation, and depression. Observational studies suggest that CBD has the potential to mitigate symptoms that interfere with sleep and improve sleep wake cycles, reduce behavioral misconduct, and regulate mood disorders.
CBD Offers Alzheimer's Patients Hope
In conclusion, CBD's Neuroprotective and behavioral benefits make it a promising therapeutic strategy for Alzheimer's disease. More research is necessary to understand the full extent of its benefits. But, CBD's potential for managing symptoms and slowing the disease's progression offers hope for individuals with Alzheimer's and their loved ones.
Not sure where to start? We carry many Full-Spectrum CBD options such as: